CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on novel targeted medicines primarily for cancer treatment, today announced that the company will be presenting at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference, being held April 11th and 12th. The company’s presentation will take place on Wednesday, April 11th, at 11:30 a.m. in Room 3.05, with a 30-minute breakout session immediately following in Room 3.06 at the Millennium Broadway Hotel in New York City.
